Enorama Pharma AB (publ)

kr 0.80As of Sun 8 Nov 2026, 12:00 UTC
STO:ERMAHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (18.59%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.76
PE TTM —
TSR TTM (71.43%)
Mkt cap kr 59.67M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.00
24.71%
(0.82%)
Hold 11|11|9|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.02
0.02
0.02
0.02
24.23%
20.14%
8.17%
9.32%
Revenuekr M
5.630
5.886
5.978
6.220
7.25%
8.23%
8.59%
12.51%
Peers (US$6.033M)
Cap (US$)
PE
7.846M
—
4.830M
0.121x
6.093M
—
Capital
TTM
5Y
10Y
Leveragex
0.299
0.408
0.396
EBIT/Intx
1.838
0.612
0.504
Own earn%
16.06
18.43
18.69
Sh yield%
45.85
42.14
41.84
Owners
Insiders/Inst%
13.24
37.21
Short interest%
3.24
SBC / revenue%
2.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
22–28
$1 testx
0.0
Incr. ROIC%
4